Mink Therapeutics Inc (INKT) stock has fallen -47.98% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives INKT stock a score of 26 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 4. INKT's rank also includes a long-term technical score of 4.
INKT has an Overall Score of 26. Find out what this means to you and get the rest of the rankings on INKT!
Mink Therapeutics Inc (INKT) stock is up 30.34% while the S&P 500 is up 0.33% as of 1:57 PM on Wednesday, May 3. INKT is up $0.27 from the previous closing price of $0.89 on volume of 877,509 shares. Over the past year the S&P 500 is down -1.02% while INKT has fallen -47.98%. INKT lost -$0.83 per share in the over the last 12 months.
Click Here to get the full Stock Report for Mink Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
